A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses

Triple-negative breast cancer is a heterogeneous disease characterized by a lack of hormonal receptors and HER2 overexpression. It is the only breast cancer subgroup that does not benefit from targeted therapies, and its prognosis is poor. Several studies have developed specific molecular classifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Prado-Vázquez, Guillermo, Gámez-Pozo, Angelo, Trilla-Fuertes, Lucía, Arevalillo, Jorge M., Zapater-Moros, Andrea, Ferrer-Gómez, María, Díaz-Almirón, Mariana, López-Vacas, Rocío, Navarro, Hilario, Maín, Paloma, Feliú, Jaime, Zamora, Pilar, Espinosa, Enrique, Fresno Vara, Juan Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367406/
https://www.ncbi.nlm.nih.gov/pubmed/30733547
http://dx.doi.org/10.1038/s41598-018-38364-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367406/
https://www.ncbi.nlm.nih.gov/pubmed/30733547
http://dx.doi.org/10.1038/s41598-018-38364-y

Ejemplares similares